|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/24 | |
| A61P 37/02 | |||
| A61P 37/08 |
| (11) | Patento numeris | 2436697 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11181891.0 |
| Europos patento paraiškos padavimo data | 2005-06-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-04-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-03-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0414799 | 2004-07-01 | GB | |
| 0423675 | 2004-10-25 | GB |
| (72) |
Ashman, Claire, GB
Cassidy, Martin John, GB
Ellis, Jonathan Henry, GB
Wattam, Trevor Anthony Kenneth, GB
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | Chimeric and humanised monoclonal antibodies against interleukin-13 |
| Chimeric and humanised monoclonal antibodies against interleukin-13 |